
Bristol’s much-loved 10k running event returns in May 2025
At 26, Steve, a musician from Birmingham, was diagnosed with T-Cell Acute Lymphoblastic Leukaemia and joined the ALL-Together-1 clinical trial.
Diary of Sara, an Acute Lymphoblastic Leukaemia (ALL) Patient.
Markas beat leukaemia at just 3 years old, and his story shows why the ATICUS Network is vital for giving children access to life-saving treatments.
On World AML Awareness Day, through continued investment in the Trials Acceleration Programme (TAP) network, Cure Leukaemia are proud to announce two major clinical trials are on the horizon, EVOLVE 1 and 2.
With a new blood cancer diagnosis every 27 seconds worldwide, Cure Leukaemia funds research nurses and clinical roles at blood cancer centres across the UK, providing patients with access to innovative and potentially life-saving treatments through clinical trials. By supporting these roles, Cure Leukaemia facilitates potentially life-saving advancements in blood cancer therapies nationally but also contributes to global progress and hope for those impacted by the disease worldwide.
Make a donation to support our national network of specialist research nurses.
Find out moreNotifications